Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v4-EN
Language English English
Date Updated 2023-06-21 2023-06-20
Drug Identification Number 02309556 02309556
Brand name TEVA-CYPROTERONE / ETHINYL ESTRADIOL TEVA-CYPROTERONE / ETHINYL ESTRADIOL
Common or Proper name TEVA-CYPROTERONE / ETHINYL ESTRADIOL TEVA-CYPROTERONE / ETHINYL ESTRADIOL
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients ETHINYL ESTRADIOL CYPROTERONE ACETATE ETHINYL ESTRADIOL CYPROTERONE ACETATE
Strength(s) 0.035MG 2MG 0.035MG 2MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 21 21
ATC code G03HB G03HB
ATC description ANTIANDROGENS ANTIANDROGENS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-06-08 2023-06-08
Estimated end date 2023-06-20 2023-06-20
Actual end date 2023-06-20 2023-06-20
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments